Nitya G. Ray
Net worth: 57 302 $ as of 2024-03-30
Profile
Nitya G.
Ray worked as a Director of Bioprocess Development at Forticell Bioscience, Inc. from 1997 to 2001.
He then worked at Progenics Pharmaceuticals, Inc. for 17 years, starting as a Senior Vice President of Manufacturing in 2001 and ending as an Executive Vice President in 2018.
In 2017, he briefly worked as an Executive Vice President at Actinium Pharmaceuticals, Inc. before becoming the Chief Technology Officer at CytoDyn, Inc. in 2018.
Dr. Ray received his undergraduate degree from Jadavpur University and his graduate and doctorate degrees from Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYTODYN INC.
0.04% | 2023-09-10 | 351,545 ( 0.04% ) | 57 302 $ | 2024-03-30 |
Former positions of Nitya G. Ray
| Companies | Position | End |
|---|---|---|
| CYTODYN INC. | Chief Operating Officer | 2022-04-18 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-12-20 |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-09-30 |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Corporate Officer/Principal | 2000-12-31 |
Training of Nitya G. Ray
| Rutgers State University of New Jersey | Doctorate Degree |
| Jadavpur University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CYTODYN INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Nitya G. Ray
